Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

SUTRO BIOPHARMA, INC.

(STRO)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 03-10-2022
5.790 USD   +4.32%
23/08Sutro Biopharma, Inc. : Truist Securities herhaalt koopadvies voor het aandeel
MM
09/08Sutro Biopharma, Inc. : Berenberg Bank herhaalt koopadvies
MM
08/08Sutro Biopharma, Inc. Rapporteert Winstresultaten voor het Tweede Kwartaal en de Zes Maanden Geëindigd op 30 Juni, 2022
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op SUTRO BIOPHARMA, INC.
09/09Transcript : Sutro Biopharma, Inc. Presents at 2022 Wells Fargo Healthcare Co..
01/09Sutro Biopharma to Present at the 2022 Wells Fargo Healthcare Conference
19/08Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/08Transcript : Sutro Biopharma, Inc. Presents at 13th Annual Wedbush PacGrow He..
08/08Sutro Biopharma : Reports Second Quarter 2022 Financial Results, Business Highlights and A..
08/08SUTRO BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and ..
08/08Sutro Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months En..
08/08Earnings Flash (STRO) SUTRO BIOPHARMA Posts Q2 Revenue $28.1M
08/08Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and ..
03/08Sutro Biopharma to Present at the 2022 Wedbush PacGrow Healthcare Conference
27/07Sutro Biopharma Achieves 'First in Human' Milestone in Cytokine Derivatives Collaborati..
26/07Sutro Biopharma, Inc. : Other Events (form 8-K)
26/07Sutro Biopharma Achieves “First in Human” Milestone in Cytokine Derivatives..
20/07Transcript : Sutro Biopharma, Inc. - Special Call
12/07Sutro Biopharma Announces Virtual De : Next-Gen Innovations in ADCs
28/06Sector Update: Health Care Stocks Decline Tuesday but Largely Outperform M..
28/06Sector Update: Health Care
28/06Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday
28/06Sutro Biopharma Shares Rise 24% After Collaboration With Astellas Pharma
28/06Sutro Biopharma, Inc. : Entry into a Material Definitive Agreement, Other Events, Financia..
28/06Sutro Biopharma, Astellas Pharma to Collaborate on Antibody-Drug Conjugates for Cancers
28/06Astellas and Sutro Biopharma†Announce Worldwide Strategic Collaboration to Advance Nove..
28/06Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Nove..
28/06Sutro Biopharma Shares Soar 67% on Cancer Treatment Collaboration with Astellas
24/06Sutro Biopharma, Inc.(NasdaqGM:STRO) dropped from Russell..
24/06Sutro Biopharma, Inc.(NasdaqGM:STRO) dropped from Russell..
24/06Sutro Biopharma, Inc.(NasdaqGM:STRO) dropped from Russell..
24/06Sutro Biopharma, Inc.(NasdaqGM:STRO) dropped from Russell..
24/06Sutro Biopharma, Inc.(NasdaqGM:STRO) dropped from Russell..
24/06Sutro Biopharma, Inc.(NasdaqGM:STRO) dropped from Russell..
24/06Sutro Biopharma : 22nd Annual Federation of Clinical Immunology Societies (FOCIS) Meeting ..
21/06Sutro Biopharma, Inc.(NasdaqGM:STRO) dropped from S&P Bio..
16/06Sutro Biopharma : JMP Securities Life Sciences Conference – Presentation
16/06Sutro Biopharma, Inc. : Other Events, Financial Statements and Exhibits (form 8-K)
07/06Sutro Biopharma, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K)
06/06Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
04/06Sutro Biopharma : 2022 ASCO Annual Meeting – Abstract
03/06Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/06Sutro Biopharma : Bill Newell, CEO Interviewed by Dr. Michelle McMurry-Heath on I Am Bio P..
02/06Sutro Biopharma : Participated in a Clinical Trial, “Egg-Derived Anti-SARS-CoV-2 Imm..
02/06Sutro Biopharma to Participate in Upcoming Investor Conferences
09/05SUTRO BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and ..
09/05Sutro Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 20..
09/05Earnings Flash (STRO) SUTRO BIOPHARMA Posts Q1 Revenue $5.9M
09/05Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and ..
02/05Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
29/04Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/04Sutro Biopharma, Inc. : Entry into a Material Definitive Agreement (form 8-K)
11/04Sutro Biopharma : Kristin Bedard, Ph.D., VP of Discovery interviewed by Gail Dutton, BioSp..
08/04Sutro Biopharma : American Association for Cancer Research (AACR) Annual Meeting 2022 &nda..
08/04Sutro Biopharma, Inc. Presents Nonclinical Data for Antibody-Drug Conjugate STRO-002 at..
05/04Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference
30/03Sutro Biopharma Provides Update on Cancer Tumor Treatment Technology
30/03Sutro Biopharma : 12th Annual World ADC London 2022 – Presentations
30/03Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-Drug Conjugat..
03/03Sutro Biopharma to Participate in the Cowen 42nd Annual Healthcare Conference
01/03Sutro Biopharma : Reports Full Year 2021 Financial Results, Business Highlights, and Antic..
28/02SUTRO BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and ..
28/02Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anti..
28/02Sutro Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 202..
13/01Transcript : Sutro Biopharma, Inc. Presents at JPMorgan 40th Annual Healthcar..
11/01Sutro Biopharma : 63rd American Society of Hematology (ASH) Annual Meeting and Exposition ..
10/01Sutro Biopharma : 40th Annual J.P. Morgan Heathcare Conference – Presentation
10/01Sutro Biopharma, Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
06/01Top Premarket Decliners
06/01Sutro Biopharma to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
06/01Sutro Early-Stage Ovarian Cancer Study Shows 33% Objective Response Rate -- Shares Drop..
05/01MT Newswires After Hours Watch List: SLGC, STRO, BLI
05/01Sutro Biopharma : Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 St..
05/01Sutro Biopharma : 2022 KOL Discussion of STRO-002 Phase 1 Interim Dose Expansion Data &nda..
05/01Sutro Biopharma, Inc. : Regulation FD Disclosure, Other Events, Financial Statements and E..
05/01Sutro Says Interim Data From STRO-002 Early-Stage Study Shows 33% Objective Response Ra..
05/01Transcript : Sutro Biopharma, Inc. - Special Call
05/01Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 S..
05/01Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 S..
2021Sutro Biopharma's China Licensing Deal Bolsters Case Ahead Next Week's Interim Dose Exp..
2021Health Care Stocks Firming Ahead of Monday's Close
2021Sector Update: Health Care
2021Sutro Biopharma's China Licensing Deal Bolsters Case Ahead Next Week's Interim Dose Exp..
2021Health Care Stocks Mixed Premarket Monday
2021Sutro Biopharma Signs Tasly to Develop, Commercialize Cancer Drug in Greater China
2021Sutro Biopharma, Inc. : Entry into a Material Definitive Agreement (form 8-K)
2021Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion D..
2021Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for..
2021Sutro Biopharma, Inc. Enters into Licensing Agreement with Tasly Biopharmaceuticals Co...
2021Sutro Biopharma, Inc. Announces Company Kol Virtual Event to Provide Interim Dose Expan..
2021Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for..
2021Fred Hutchinson Cancer Research Center, in Partnership with Sutro Biopharma, to Present..
2021Fred Hutchinson Cancer Research Center, in Partnership with Sutro Biopharma, to Present..
2021Sutro Biopharma : 4th Annual Evercore ISI HeathCONx Conference – Presentation
2021Sutro Biopharma : Piper Sandler 33rd Annual Healthcare Conference – Presentation
2021Sutro Biopharma to Participate in Two Upcoming Investor Conferences
2021Sutro Biopharma : Jefferies London Healthcare Conference – Presentation
2021Sutro Biopharma, Inc. : Change in Directors or Principal Officers (form 8-K)
2021Sutro Biopharma Announces Appointment of Heidi Hunter to Board of Directors
2021Sutro Biopharma, Inc. Announces Appointment of Heidi Hunter to Board of Directors, Memb..
2021Sutro Biopharma : Stifel 2021 Virtual Healthcare Conference – Presentation
2021Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and ..
2021Transcript : Sutro Biopharma, Inc. Presents at 30th Annual Credit Suisse Heal..
2021Sutro Biopharma Q3 Loss Widens as Revenue Declines
Volgende evenement op SUTRO BIOPHARMA, INC.